In-vitro analysis showed that both protocols are efficient in priming a proper MM-specific immune response, as both CD4+ T cells and CD8+ CTL were expanded in numbers upon co-culture with the loaded moDCs. The gene discussed is CD4; the disease is Miyoshi myopathy.